Nattokinase
Research Summary
Nattokinase is a potent proteolytic enzyme extracted and purified from natto, a traditional Japanese food made from fermented soybeans. It is a serine protease produced by the bacterium Bacillus subtilis var. natto during the fermentation process. Unlike most soy foods, nattokinase is specifically valued for its unique enzymatic activity rather than its nutritional content. It has been a cornerstone of cardiovascular research in Japan since its discovery in 1980 by Dr. Hiroyuki Sumi, and it is increasingly recognized globally for its role in supporting vascular health and longevity.
Nattokinase primarily works through its fibrinolytic activity, which means it dissolves fibrin, the protein responsible for blood clot formation. It operates via a dual-pathway mechanism: it directly cleaves cross-linked fibrin and simultaneously enhances the body's natural production of plasmin and tissue plasminogen activator (t-PA) while inhibiting plasminogen activator inhibitor-1 (PAI-1). Additionally, nattokinase has been shown to inhibit Angiotensin-Converting Enzyme (ACE), which helps reduce peripheral vascular resistance and lower blood pressure. Emerging research also suggests it reduces blood viscosity and possesses anti-atherosclerotic properties by improving lipid metabolism and reducing arterial plaque formation.
Key Benefits
• Potent Fibrinolytic Effect: Highly effective at breaking down blood clots and preventing deep vein thrombosis (DVT). • Blood Pressure Support: Proven to modestly reduce both systolic and diastolic blood pressure (Kim et al., 2008; Li et al., 2023). • Atherosclerosis Management: High-dose clinical trials show up to a 36% reduction in carotid plaque size. • Improved Lipid Profile: Supports the reduction of LDL cholesterol and triglycerides while increasing HDL levels.
Considerations
• Bleeding Risk: The potent blood-thinning effect may cause bruising or prolonged bleeding, especially in those with coagulation disorders. • Drug Interactions: High risk of interaction with pharmaceutical blood thinners and blood pressure drugs. • Soy Sensitivity: Though purified, individuals with severe soy allergies should use caution. • Data Gaps: While it effectively improves markers like plaque and BP, there is a lack of massive, multi-decade mortality trials compared to standard therapies like statins.
Based on the latest clinical evidence: Dosage: For general cardiovascular maintenance, 2,000 to 4,000 FU (Fibrinolytic Units) daily is common. However, recent landmark research (Chen et al., 2022) indicates that higher doses, such as 10,800 FU daily, are necessary for measurable reduction in arterial plaque and significant lipid improvement. Administration: Take on an empty stomach—at least 30 minutes before or 2 hours after a meal—to ensure the enzyme is absorbed into the bloodstream. Duration: Clinical safety has been established for continuous use up to 3 years. Medical Supervision: Essential for individuals taking anticoagulants (Warfarin, Eliquis), antiplatelet drugs (Aspirin), or antihypertensive medications due to the risk of additive effects. Surgery: Discontinue use at least 14 days prior to any surgical or dental procedures to prevent excessive bleeding.
Community Experiences
No posts about Nattokinase yet. Be the first to share something!
The information provided on this page is NOT medical advice. Please consult a doctor before using a product or making lifestyle changes.